{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:24:11Z","timestamp":1726759451861},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.thromres.2011.08.012","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T05:44:20Z","timestamp":1315719860000},"page":"3-8","source":"Crossref","is-referenced-by-count":10,"title":["Filling the gap between science & clinical practice: Prevention of stroke recurrence"],"prefix":"10.1016","volume":"129","author":[{"given":"Anna","family":"Russolillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo Nicola Dario","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Tufano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.08.012_bb0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jacc.2009.12.072","article-title":"Stroke Prevention and Treatment","volume":"56","author":"Marsh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2011.08.012_bb0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(03)14544-8","article-title":"Stroke","volume":"362","author":"Warlow","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.08.012_bb0015","doi-asserted-by":"crossref","first-page":"483S","DOI":"10.1378\/chest.126.3_suppl.483S","article-title":"Antithrombotic and Thrombolytic therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic therapy","volume":"126","author":"Albers","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.08.012_bb0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an indipendent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2011.08.012_bb0030","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.08.012_bb0035","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.thromres.2011.08.012_bb0040","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation","volume":"31","author":"The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2011.08.012_bb0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.08.012_bb0050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejim.2010.07.014","article-title":"Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards","volume":"21","author":"Marcucci","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1212\/01.wnl.0000201253.93811.f6","article-title":"Recurrent stroke and cardiac risk after first ischemic stroke: the Northen Manhattan Study","volume":"66","author":"Dhamoon","year":"2006","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2011.08.012_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000069936","article-title":"Long-term outcome after ischaemic stroke\/transient ischaemic attack","volume":"16","author":"Hankey","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.thromres.2011.08.012_bb0065","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1161\/01.STR.0000092488.40085.15","article-title":"Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review","volume":"34","author":"Rashid","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2011.08.012_bb0070","series-title":"Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack","year":"2008"},{"key":"10.1016\/j.thromres.2011.08.012_bb0075","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/STROKEAHA.107.189063","article-title":"Update to the AHA\/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack","volume":"39","author":"Adams","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2011.08.012_bb0080","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/STROKEAHA.108.521419","article-title":"The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry","volume":"40","author":"Weimar","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2011.08.012_bb0085","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1586\/erc.09.106","article-title":"Statins and stroke prevention","volume":"7","author":"Paciaroni","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.thromres.2011.08.012_bb0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischaemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0095","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2011.08.012_bb0100","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol education Program (NCEP) export Panel of Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2011.08.012_bb0105","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/eurheartj\/ehp355","article-title":"Three-Year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry","volume":"30","author":"Alberts","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2011.08.012_bb0110","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1007\/s10072-006-0633-8","article-title":"The stroke in Italy and related impact on outcome (SIRIO) study: design and baseline data","volume":"27","author":"Toso","year":"2006","journal-title":"Neurol Sci"},{"key":"10.1016\/j.thromres.2011.08.012_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00149831-200504000-00011","article-title":"Cholesterol control in stroke prevention in Italy: a cross-sectional study in family practice","volume":"12","author":"Filippi","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.thromres.2011.08.012_bb0120","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/01.STR.0000062888.90293.AA","article-title":"Secondary prevention of stroke in Italy: a cross-sectional survey in family practice","volume":"34","author":"Filippi","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2011.08.012_bb0125","first-page":"429","article-title":"Management of patients with suspected angina, but without known myocardial infarction: a cross-sectional survey","volume":"54","author":"Filippi","year":"2004","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.thromres.2011.08.012_bb0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000113864","article-title":"Risk Factors and Treatment at Recurrent Stroke Onset: Results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study","volume":"25","author":"Leoo","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.thromres.2011.08.012_bb0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.08.012_bb0145","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.158.19.2093","article-title":"Warfarin use following ischemic stroke among medicare patients with atrial fibrillation","volume":"158","author":"Brass","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0150","doi-asserted-by":"crossref","first-page":"b5216","DOI":"10.1136\/bmj.b5216","article-title":"Management of atrial fibrillation","volume":"339","author":"Lafuente","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2011.08.012_bb0155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial","volume":"348","author":"Stroke Preventionin Atrial Fibrillation","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.08.012_bb0160","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","article-title":"Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study","volume":"158","author":"Gull\u00f8v","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000047711","article-title":"Anticoagulant (fluindione)-aspirin combination in patients with highrisk atrial fibrillation: a randomized trial","volume":"12","author":"Lechat","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.thromres.2011.08.012_bb0170","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2004.05.084","article-title":"Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and non-valvular atrial fibrillation: a randomized multicenter study","volume":"44","author":"Perez-Gomez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2011.08.012_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11739-010-0349-x","article-title":"Combined oral anticoagulants and antiplatelets: benefits and risks","volume":"5","author":"Vedovati","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0180","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"ACTIVE Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0185","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"ACTIVE Writing Group of the ACTIVE Investigators","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.08.012_bb0190","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.amjcard.2009.03.022","article-title":"Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy","volume":"104","author":"Ben-Dor","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2011.08.012_bb0195","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.08.012_bb0200","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/01.CIR.0000015422.86569.52","article-title":"Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?","volume":"105","author":"Halushka","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.08.012_bb0205","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1160\/TH09-06-0418","article-title":"Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An update meta-analysis","volume":"103","author":"Sofi","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.08.012_bb0210","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomized controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.08.012_bb0215","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus Clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet inhibition and Patient Outcomes (PLATO) trial subgroup analysis","volume":"122","author":"Steg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.08.012_bb0220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2174\/157016111797484189","article-title":"New Anti-Thrombotic Drugs for Stroke Prevention","volume":"9","author":"Di Minno","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.thromres.2011.08.012_bb0225","doi-asserted-by":"crossref","first-page":"445S","DOI":"10.1378\/chest.114.5_Supplement.445S","article-title":"Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2011.08.012_bb0230","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0235","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMc1007378","article-title":"Randomized Evaluation of Long-Term Anticoagulation Therapy Investigators. Newly identified events in the RE-LY trial","volume":"363","author":"Connolly","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.08.012_bb0240","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ahj.2009.11.025","article-title":"Rivaroxaban \u2014 Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study","volume":"159","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2011.08.012_bb0245","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.hoc.2010.05.006","article-title":"Oral Xa inhibitors","volume":"24","author":"Romualdi","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.thromres.2011.08.012_bb0250","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/jama.295.16.1912","article-title":"Association between hospital process performance and outcomes among patients with acute coronary syndromes","volume":"295","author":"Peterson","year":"2006","journal-title":"JAMA"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811004348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811004348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T05:00:18Z","timestamp":1543554018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811004348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0049384811004348"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.08.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}